Ykrita
1 known investors
Ykrita develops the EBDLR System, a bioengineered liver-assist device that supports blood purification and regeneration for patients with acute liver failure, offering an alternative to transplant surgery. The company focuses on innovative medical technologies to improve patient outcomes and make healthcare more accessible and effective.
Investors Β· 1
Frequently asked questions
- What does Ykrita do?
- Ykrita develops the EBDLR System, a bioengineered liver-assist device that supports blood purification and regeneration for patients with acute liver failure, offering an alternative to transplant surgery. The company focuses on innovative medical technologies to improve patient outcomes and make healthcare more accessible and effective.
- Who are Ykrita's investors?
- Ykrita's investors include Inflexor Ventures.